Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Artigo em Russo | MEDLINE | ID: mdl-18825946

RESUMO

The aims of this study were to estimate of psychomotor activity, emotional status and magnesium (Mg) content in blood of rats fed with Mg-deficient diet for 49 days; and to find out whether the combination of vitamin B6 with Mg will reveal antidepressant- and anxiolytic-like activity and reduce the length of the treatment needed to recover rats from Mg-deficient condition. To induce hypomagnesemia, seventy-nine rats were placed on a Mg-deficient diet (Mg content < or = 15 mg/kg) and demineralized water for 7 weeks. Eight control rats were fed a basal control diet. On the forty-ninth day of Mg-deficient diet, rats were treated one of the six supplementations: Mg L-aspartate alone and in combination with pyridoxine, MgCl2 x 6H2O alone and in combination with pyridoxine, Magne B6 (Mg lactate with pyridoxine) and Mg sulfate (50 mg Mg and 5 mg vitamin B6 per kg). In our study Mg-deficiency was associated with depleted intraerythrocytic (0.748 +/- 0.036 vs. 1.83 +/- 0.026 mmol/l, p < 0.001) and plasma (0.567 +/- 0.029 vs. 1.20 +/- 0.030 mmol/l, p < 0.001) Mg level compared to control rats. It was shown Mg deficiency resulted in depression-like and anxiety-related behavior in rats. Open field test result in rats including locomotor activity (number of crossed squares) and vertical activity (number of standing on hind paws), number of visiting in central squares were decreased significantly. In the elevated plus maze test, the number of visiting open arms (by 63.6%) and residence time (by 78.5%) of rats were significantly less as compared with the control group. In the forced swimming test, time immobile was significantly increased (by 70.2%) and time of swimming was decreased (by 15%) compared to control. Mg salts alone and in combination with vitamin B6 administered to Mg-deficient rats increased the Mg level in plasma and erythrocytes. Furthermore, this increase was in relation to vitamin B6 given to the animal. It was established, that the application of Mg L-aspartate and MgCl2 x 6H2O in combinations with pyridoxine led to correction of behavioural disturbances of Mg-deficient animals. Antidepressant- and anxiolytic-like activity of studied salts was comparable with those observed in Magne B6 treatment and significantly higher than in Mg sulfate treatment.


Assuntos
Ansiedade/fisiopatologia , Ácido Aspártico/uso terapêutico , Depressão/fisiopatologia , Compostos de Magnésio/uso terapêutico , Deficiência de Magnésio/tratamento farmacológico , Animais , Ansiedade/tratamento farmacológico , Depressão/tratamento farmacológico , Suplementos Nutricionais , Masculino , Ratos
2.
Eksp Klin Farmakol ; 71(4): 35-40, 2008.
Artigo em Russo | MEDLINE | ID: mdl-18819439

RESUMO

Low serum magnesium (Mg) concentrations have been reported in patients with atherosclerosis. From the other hand numerous clinical reports suggest the beneficial effects of Mg adjuvant therapy for the treatment of atherosclerosis. The purpose of this present study was to compare the effect of Mg L-aspartate and Mg chloride alone and in combinations with pyridoxine, Mg sulfate and Magne B6 (Mg lactate with pyridoxine) on lipid profile in rats fed with Mg deficient diet. To induce hypomagnesemia, fifty-three rats were placed on a Mg-deficient diet (ICN Biomedicals Inc. Aurora, OH) and demineralized water for 7 weeks. Seven control rats were fed a basal control diet (Mg content = 500 mg/kg) and water (with Mg content 20 mg/l) for equal duration. On the forty-ninth day of Mg-deficient diet, rats were treated one of the six supplementations: Mg chloride, Mg L-aspartate alone and in combinations with pyridoxine, Mg sulphate and Magne B6 (50 mg Mg and 5 mg vitamin B6 per kg). In our study Mg deficiency resulted in increase of triglyceride (by 35.2 %p < 0.0001), LDL (more than fourfold p < 0.0001), total cholesterol (by 38.7% p < 0.0001), apolipoprotein B (by 74.1%, p = 0.0006) levels and decrease in concentration of HDL (by 28.7% p < 0.0001). The non-HDL cholesterol/HDL cholesterol ratio was more than threefold increased (p < 0.0001). Oral magnesium salts led to normalization of lipid state with a return to pre-deficient levels. Magnesium salts in combinations with pyridoxine tended to be significantly more effective as compared with salts without pyridoxine. The hypolipidemic effect of studied salts was comparable with those observed in Magne B6 treatment and significantly higher than in magnesium sulfate treatment.


Assuntos
Ácido Aspártico/farmacologia , Lipoproteínas/sangue , Compostos de Magnésio/farmacologia , Deficiência de Magnésio/metabolismo , Animais , Ácido Aspártico/administração & dosagem , Colesterol/sangue , Dieta , Interações Medicamentosas , Lipoproteínas HDL/sangue , Lipoproteínas VLDL/sangue , Compostos de Magnésio/administração & dosagem , Masculino , Piridoxina/administração & dosagem , Piridoxina/farmacologia , Ratos , Triglicerídeos/sangue , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/farmacologia
3.
Vopr Pitan ; 77(6): 62-71, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19227867

RESUMO

Aims of our work were to appraise the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rats; and to find out whether the combination of pyridoxine with Mg L-aspartate or Mg chloride will reduce the length of the treatment needed to recover rats from magnesium deficient condition and urolithiasis state. To induce hypomagnesemia, fifty rats were placed on a magnesium-deficient diet (magnesium content < or = 15 mg/kg) and demineralized water for 10 weeks. On the forty-ninth day of magnesium-deficient diet, rats were treated one of the six supplementations: MgCl2, Mg-L-Asp or their combinations with pyridoxine hydrochloride, magnesium sulfate, magne B6.


Assuntos
Compostos de Magnésio/uso terapêutico , Deficiência de Magnésio/complicações , Nefrolitíase/tratamento farmacológico , Nefrolitíase/etiologia , Animais , Ácido Aspártico/administração & dosagem , Ácido Aspártico/uso terapêutico , Modelos Animais de Doenças , Ácido Láctico/administração & dosagem , Ácido Láctico/uso terapêutico , Compostos de Magnésio/administração & dosagem , Deficiência de Magnésio/sangue , Deficiência de Magnésio/tratamento farmacológico , Masculino , Nefrolitíase/sangue , Ratos , Resultado do Tratamento , Vitamina B 6/administração & dosagem , Vitamina B 6/uso terapêutico
4.
Vopr Pitan ; 76(5): 67-73, 2007.
Artigo em Russo | MEDLINE | ID: mdl-18030818

RESUMO

The purpose of the present research was comparative study of anti-inflammatory action of some Mg salts in rats fed with Mg-deficient diet. It was shown in our study that administration of Mg L-aspartate with pyridoxine leads to higher compensation of Mg deficiency in rats with diet-induced Mg depletion as compared with other Mg supplementations. According to the Mg deficiency correction rate Mg salts may be ranged in the following order: Mg L-aspartate with pyridoxine > or = Mg chloride with pyridoxine > or = Mg lactate with pyridoxine > or = Mg L-aspartate > Mg chloride > Mg orotate. In our study administration of Mg salts resulted in decreased number of blood leukocytes, reduced peripheral vasodilation visible in the external ear, decreased spleen weight, and as consequences in reduced inflammatory and immunological response. According to correction rate of the inflammatory response Mg salts may be ranged in the following order: Mg orotate > or = Mg chloride > or = Mg chloride with pyridoxine > or = Mg L-aspartate > or = MgL-aspartate with pyridoxine > or = Mg lactate with pyridoxine.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Suplementos Nutricionais , Alimentos Formulados , Deficiência de Magnésio/dietoterapia , Magnésio/administração & dosagem , Animais , Inflamação/dietoterapia , Inflamação/imunologia , Inflamação/metabolismo , Inflamação/patologia , Contagem de Leucócitos , Deficiência de Magnésio/sangue , Deficiência de Magnésio/imunologia , Deficiência de Magnésio/patologia , Masculino , Tamanho do Órgão , Ratos , Sais/administração & dosagem , Baço/imunologia , Baço/metabolismo , Baço/patologia , Vasodilatação/efeitos dos fármacos , Vasodilatação/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA